WiresConnect Sets Stage for Second Conference with Keynote Deborah Weinswig of Coresight Research and Featured Guest Daymond John, FUBU CEO and ABC’s Shark Tank Star
Conference sessions will explore how AI, sustainability, social commerce, and emerging innovations are redefining the fashion, beauty, and retail ecosystem NEW YORK–(BUSINESS... Read more.
Mice Model Market Trends and Growth Opportunities by Segment & Region 2025-2032 – Transformative Innovations in Genetic Engineering Propel Mice Model Research in Oncology and Rare Diseases – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Mice Model Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering.... Read more.
ONDA Continues Growth With Two New Associate Hires
Emerging family law attorneys join one of Texas’ largest family law practices DALLAS–(BUSINESS WIRE)–Orsinger, Nelson, Downing & Anderson is pleased... Read more.
Constellation Reaches Resolution With U.S. Department of Justice for Calpine Transaction
Final regulatory clearance paves the way for closing, delivering benefits for customers and communities across America BALTIMORE–(BUSINESS WIRE)–Constellation... Read more.
Blue Owl Capital Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – OWL
LOS ANGELES–(BUSINESS WIRE)–The DJS Law Group reminds investors of a class action lawsuit against Blue Owl Capital Inc. (“Blue Owl” or “the Company”)... Read more.
KBRA Assigns Preliminary Ratings to GCAT 2025-INV5 Trust
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to 71 classes of mortgage-backed notes from GCAT 2025-INV5 Trust.... Read more.
AM Best Assigns Issue Credit Rating to Victor Insurance Exchange’s Surplus Notes
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance—AM Best has assigned a Long-Term Issue Credit Rating of “bbb” (Good) to the $102.5 million, 6% surplus... Read more.
PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
LYT-200 demonstrated favorable tolerability and strong efficacy in a heavily pretreated population, both in combination with standard of care and as a monotherapy,... Read more.
Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome
– Median seizure reduction of 78% through seven months of observation at the third dose level – – Clinically meaningful gains in multiple measures of neurodevelopment... Read more.
Cerebras AI Inference Wins Demo of the Year Award at TSMC North America Technology Symposium
World’s Leading AI Inference Selected by Innovation Zone Attendees at TSMC’s North America Technology Symposium SUNNYVALE, Calif.–(BUSINESS WIRE)–#AI—Cerebras... Read more.